With the goal of solving these problems, Tensive created the project REGENERA to develop a cell-free porous scaffold made of resorbable biomaterials with a biomimetic architecture which aims to promote blood vessels and soft tissue recruitment. It is designed to be gradually replaced by the patients’ soft tissue, allowing to restore a natural aspect and feeling of the reconstructed breast. The technology has not yet been tested in humans.

REGENERA project has been funded by the European Union's Horizon 2020 research and innovation programme, under grant agreement No 812002, for a total budget of €2.69 million. The goal of the project is to complete the development of a breakthrough solution for breast reconstruction, in particular for post-lumpectomy patients, for whom there are no definitive, optimal reconstructive options available.

Allergan loses CE mark for textured breast implants

Allergan loses CE mark for textured breast implants

December 20, 2018